Problems for risk assessment of endocrine-active estrogenic compounds.
2002 ◽
Vol 110
(suppl 6)
◽
pp. 925-929
◽
2015 ◽
Vol 74
(7)
◽
pp. 5961-5969
◽
1987 ◽
Vol 1
(2)
◽
pp. 147-153
◽
2017 ◽
Vol 52
◽
pp. 69-76
◽
2014 ◽
Vol 522-524
◽
pp. 111-116
◽
Keyword(s):
1998 ◽
Vol 62
(10)
◽
pp. 756-761
◽
Keyword(s):
1995 ◽
Vol 59
(10)
◽
pp. 932-940
◽
1999 ◽
Vol 63
(10)
◽
pp. 745-747
◽
Keyword(s):